KLAS Contact
Contact KLAS
Contact KLAS
2022 BEST IN KLAS
Preferences
Related Series
2022
2019
Related Segments
Related Articles
Drug Diversion Monitoring 2021
Are the Next-Gen Tools Ready for Prime Time?
Author
Jackson Tate
Author
Paul Warburton
Current Time Inside Cache Tag Helper: 9/26/2022 9:58:07 PM and Model.reportId = 1611
Static for some time, the drug diversion monitoring market has seen a recent wave of next-generation solutions that seek to streamline the investigation process by providing consolidated, prioritized insights and more proactive alerting. However, these solutions are not all created equal. This report examines the customer experience of four next-gen vendors that have achieved broader integration and adoption—FairWarning, HelioMetrics, Invistics, and Kit Check. It also provides early insights on several next-gen solutions that are in more developmental phases (BD, Medacist, and Protenus). KLAS interviewed approximately 50% of the organizations that were live with a next-gen solution at the time this research was collected.if you don't have a login, getting started is easy.
Key Findings:
- Kit Check Emerging as Most Mature Option in New Batch of Next-Gen Solutions
- Kit Check and FairWarning Best at Meeting Customers’ Expectations for Diversion Monitoring 2.0
- Vendor Performance in Key Metrics
Writer
Elizabeth Pew
Project Manager
Natalie Jamison
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.